Abu dhabi: Ethmar International Holding (EIH), a leading investment holding company in the UAE, has announced a partnership with FutureLife group to introduce the renowned Institut Marquès assisted reproductive technology (ART) centre to Abu Dhabi. The collaboration aims to bolster Abu Dhabi's reputation as a global leader in healthcare innovation and excellence. According to Emirates News Agency, the new state-of-the-art facility is scheduled to open in 2026 and will integrate seamlessly with Abu Dhabi's advanced healthcare ecosystem. Institut Marquès, founded over a century ago, is recognized internationally for its pioneering advancements and high success rates in fertility treatments. The centre's cutting-edge embryology laboratories and a multidisciplinary team of nearly 200 professionals, including gynaecologists, embryologists, and psychologists, have made it one of the highest-performing IVF providers globally, achieving success rates of up to 86 percent. Institut Marquès currently operates clinics in Barcelona, Sabadell, Rome, and Milan. The upcoming Abu Dhabi centre will extend its legacy of European clinical excellence and advanced technology to the UAE. Patients will have access to a comprehensive suite of fertility treatments and services, aligning with EIH's commitment to supporting Abu Dhabi's strategic goals in advancing medical and health tourism, and enhancing local healthcare capabilities. With infertility affecting one in six adults globally, as noted by the World Health Organisation (WHO), the introduction of Institut Marquès in Abu Dhabi is a significant step in addressing this global health challenge. EIH emphasized that bringing Institut Marquès to Abu Dhabi underscores its commitment to supporting the emirate's ambition to become a regional and global healthcare hub. The strength and legacy of Institut Marquès in Europe demonstrate its scalability and ability to deliver consistently across multiple markets. Institut Marquès is part of the FutureLife group, a global leader in reproduct ive medicine, operating over 60 clinics across 16 countries. The collaboration brings extensive expertise and clinical excellence to Abu Dhabi, with the UAE capital serving as a gateway for Institut Marquès' regional expansion in advanced reproductive medicine. FutureLife group is supported by Hartenberg, an investment firm focused on achieving investment growth and long-term value, and CVC Capital Partners (CVC), a leading global private markets firm. CVC has a history of investment in the UAE and is committed to further investments in businesses that support development across the country.